Release Date: 30/07/10 13:25 Summary: June Quarter Activities Report and Appendix 5b Price Sensitive: Yes Download Document 879.72KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%